A citation-based method for searching scientific literature

Ashley S Felix, D Scott McMeekin, David Mutch, Joan L Walker, William T Creasman, David E Cohn, Shamshad Ali, Richard G Moore, Levi S Downs, Olga B Ioffe, Kay J Park, Mark E Sherman, Louise A Brinton. Gynecol Oncol 2015
Times Cited: 21







List of co-cited articles
65 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Cell-autonomous activation of the PI3-kinase pathway initiates endometrial cancer from adult uterine epithelium.
Sanaz Memarzadeh, Yang Zong, Deanna M Janzen, Andrew S Goldstein, Donghui Cheng, Takeshi Kurita, Amanda M Schafenacker, Jiaoti Huang, Owen N Witte. Proc Natl Acad Sci U S A 2010
44
4

De Novo Epigenetic Programs Inhibit PD-1 Blockade-Mediated T Cell Rejuvenation.
Hazem E Ghoneim, Yiping Fan, Ardiana Moustaki, Hossam A Abdelsamed, Pradyot Dash, Pranay Dogra, Robert Carter, Walid Awad, Geoff Neale, Paul G Thomas,[...]. Cell 2017
377
4

ARID1A deficiency and immune checkpoint blockade therapy: From mechanisms to clinical application.
Guangyuan Hu, Wei Tu, Liu Yang, Guang Peng, Lin Yang. Cancer Lett 2020
19
5

edgeR: a Bioconductor package for differential expression analysis of digital gene expression data.
Mark D Robinson, Davis J McCarthy, Gordon K Smyth. Bioinformatics 2010
4

Exome sequencing identifies ARID2 as a novel tumor suppressor in early-onset sporadic rectal cancer.
Pratyusha Bala, Anurag Kumar Singh, Padmavathi Kavadipula, Viswakalyan Kotapalli, Radhakrishnan Sabarinathan, Murali Dharan Bashyam. Oncogene 2021
9
11


Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma.
Willy Hugo, Jesse M Zaretsky, Lu Sun, Chunying Song, Blanca Homet Moreno, Siwen Hu-Lieskovan, Beata Berent-Maoz, Jia Pang, Bartosz Chmielowski, Grace Cherry,[...]. Cell 2016
4

Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response.
Peng Jiang, Shengqing Gu, Deng Pan, Jingxin Fu, Avinash Sahu, Xihao Hu, Ziyi Li, Nicole Traugh, Xia Bu, Bo Li,[...]. Nat Med 2018
4

Genomic correlates of response to CTLA-4 blockade in metastatic melanoma.
Eliezer M Van Allen, Diana Miao, Bastian Schilling, Sachet A Shukla, Christian Blank, Lisa Zimmer, Antje Sucker, Uwe Hillen, Marnix H Geukes Foppen, Simone M Goldinger,[...]. Science 2015
4

ChAMP: updated methylation analysis pipeline for Illumina BeadChips.
Yuan Tian, Tiffany J Morris, Amy P Webster, Zhen Yang, Stephan Beck, Andrew Feber, Andrew E Teschendorff. Bioinformatics 2017
285
4

Identification of essential genes for cancer immunotherapy.
Shashank J Patel, Neville E Sanjana, Rigel J Kishton, Arash Eidizadeh, Suman K Vodnala, Maggie Cam, Jared J Gartner, Li Jia, Seth M Steinberg, Tori N Yamamoto,[...]. Nature 2017
465
4

Prevalence of PRKDC mutations and association with response to immune checkpoint inhibitors in solid tumors.
Yu Chen, Yi Li, Yanfang Guan, Yingying Huang, Jing Lin, Lizhu Chen, Jin Li, Gang Chen, Leong Kin Pan, Xuefeng Xia,[...]. Mol Oncol 2020
14
7

GSVA: gene set variation analysis for microarray and RNA-seq data.
Sonja Hänzelmann, Robert Castelo, Justin Guinney. BMC Bioinformatics 2013
4

The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data.
Ethan Cerami, Jianjiong Gao, Ugur Dogrusoz, Benjamin E Gross, Selcuk Onur Sumer, Bülent Arman Aksoy, Anders Jacobsen, Caitlin J Byrne, Michael L Heuer, Erik Larsson,[...]. Cancer Discov 2012
4

Epigenetic driver mutations in ARID1A shape cancer immune phenotype and immunotherapy.
Jing Li, Weichao Wang, Yajia Zhang, Marcin Cieślik, Jipeng Guo, Mengyao Tan, Michael D Green, Weimin Wang, Heng Lin, Wei Li,[...]. J Clin Invest 2020
66
4

ARID1A and PI3-kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion.
Mike R Wilson, Jake J Reske, Jeanne Holladay, Genna E Wilber, Mary Rhodes, Julie Koeman, Marie Adams, Ben Johnson, Ren-Wei Su, Niraj R Joshi,[...]. Nat Commun 2019
62
4

ImmuCellAI: A Unique Method for Comprehensive T-Cell Subsets Abundance Prediction and its Application in Cancer Immunotherapy.
Ya-Ru Miao, Qiong Zhang, Qian Lei, Mei Luo, Gui-Yan Xie, Hongxiang Wang, An-Yuan Guo. Adv Sci (Weinh) 2020
323
4

The emerging roles of ARID1A in tumor suppression.
Ren-Chin Wu, Tian-Li Wang, Ie-Ming Shih. Cancer Biol Ther 2014
147
4

Classification of triple-negative breast cancers based on Immunogenomic profiling.
Yin He, Zehang Jiang, Cai Chen, Xiaosheng Wang. J Exp Clin Cancer Res 2018
181
4

Functional loss of ARID1A is tightly associated with high PD-L1 expression in gastric cancer.
Young-Bae Kim, Ji Mi Ahn, Won Jung Bae, Chang Ohk Sung, Dakeun Lee. Int J Cancer 2019
45
4

Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: an interim analysis of a multicentre, open-label, single-arm, phase 2 trial.
Vicky Makker, Drew Rasco, Nicholas J Vogelzang, Marcia S Brose, Allen L Cohn, James Mier, Christopher Di Simone, David M Hyman, Daniel E Stepan, Corina E Dutcus,[...]. Lancet Oncol 2019
266
4

Targeting interferon signaling and CTLA-4 enhance the therapeutic efficacy of anti-PD-1 immunotherapy in preclinical model of HPV+ oral cancer.
Stephanie Dorta-Estremera, Venkatesh L Hegde, Ravaen B Slay, Rachel Sun, Ananta V Yanamandra, Courtney Nicholas, Sita Nookala, Gloria Sierra, Michael A Curran, K Jagannadha Sastry. J Immunother Cancer 2019
33
4

ARID1A Mutations Are Associated with Increased Immune Activity in Gastrointestinal Cancer.
Lin Li, Mengyuan Li, Zehang Jiang, Xiaosheng Wang. Cells 2019
44
4

OncoKB: A Precision Oncology Knowledge Base.
Debyani Chakravarty, Jianjiong Gao, Sarah M Phillips, Ritika Kundra, Hongxin Zhang, Jiaojiao Wang, Julia E Rudolph, Rona Yaeger, Tara Soumerai, Moriah H Nissan,[...]. JCO Precis Oncol 2017
4

ARID1A deficiency promotes mutability and potentiates therapeutic antitumor immunity unleashed by immune checkpoint blockade.
Jianfeng Shen, Zhenlin Ju, Wei Zhao, Lulu Wang, Yang Peng, Zhongqi Ge, Zachary D Nagel, Jun Zou, Chen Wang, Prabodh Kapoor,[...]. Nat Med 2018
251
4

ARID1A alterations function as a biomarker for longer progression-free survival after anti-PD-1/PD-L1 immunotherapy.
Ryosuke Okamura, Shumei Kato, Suzanna Lee, Rebecca E Jimenez, Jason K Sicklick, Razelle Kurzrock. J Immunother Cancer 2020
70
4

The Pfam protein families database: towards a more sustainable future.
Robert D Finn, Penelope Coggill, Ruth Y Eberhardt, Sean R Eddy, Jaina Mistry, Alex L Mitchell, Simon C Potter, Marco Punta, Matloob Qureshi, Amaia Sangrador-Vegas,[...]. Nucleic Acids Res 2016
4

The impact of ARID1A mutation on molecular characteristics in colorectal cancer.
Ryuma Tokunaga, Joanne Xiu, Richard M Goldberg, Philip A Philip, Andreas Seeber, Francesca Battaglin, Hiroyuki Arai, Jae Ho Lo, Madiha Naseem, Alberto Puccini,[...]. Eur J Cancer 2020
19
5

Suppression of ARID1A associated with decreased CD8 T cells improves cell survival of ovarian clear cell carcinoma.
Un Suk Jung, Kyueng Whan Min, Dong Hoon Kim, Mi Jung Kwon, HoHyun Park, Hyung Seok Jang. J Gynecol Oncol 2021
7
14

Pan-cancer analysis of ARID1A Alterations as Biomarkers for Immunotherapy Outcomes.
Tao Jiang, Xiaoxia Chen, Chunxia Su, Shengxiang Ren, Caicun Zhou. J Cancer 2020
39
4


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.